Motilal Oswal's research report on Emami
Emami reported 10% YoY sales growth in 1QFY25 (est. 8%). The domestic business grew 10% YoY, led by 9% volume growth. There was a sequential improvement in demand in the rural market. Harsh summer translated into strong demand for cooling products. The Navratna & Dermicool products posted robust 27% YoY growth. The healthcare segment reported 11% YoY growth led by new launches and strong traction on digital platform. 7 Oils in One, BoroPlus, and D2C portfolio reported 9%, 4%, and 23% YoY growth. Conversely, the severe summer hurt the pain management range (-7% YoY). Kesh King and male grooming dipped 15% and 5% YoY, respectively.
Outlook
We reiterate our BUY rating with a revised TP of INR950, based on 40x Jun’26E EPS (earlier 35x P/E multiple).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
